Provision of iQue Screening Platform
TB Research Group, National Infection Service, Public Health England (PHE) awarded a contract for the provision of iQue screening platform merging high throughput screening with high content flow cytometry to IntelliCyt Corporation. This purchase is to support the screening of antimicrobial activity on current and novel drugs against Mycobacterium tuberculosis. The iQue Plus Screener is the only instrument on the market capable of the speeds required for this work, as it can analyse samples from a full 96-well plat...
Buyer
Public Health England
Value
£300,000
Published
16 Feb 2017
Closes
1 Feb 2017
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
16 Feb 2017
Contract ends
15 Feb 2022
CPV classifications
38434510
Cytometers
Lots
Lot default Provision of iQue Screening Platform
£200,000
TB Research Group, National Infection Service, Public Health England (PHE) awarded a contract for the provision of iQue screening platform merging high throughput screening with high content flow cytometry to IntelliCyt Corporation. This purchase is to support the screening of antimicrobial activity on current and novel drugs against Mycobacterium tuberculos...
Delivery: South West · United Kingdom, South West, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
16 Feb 2017
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.